Elisigen
PrivateLast Round
Series C
Jan 19, 2026
Est. Valuation
$179M
Total Funding Raised
$78.45M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Elisigen is a biotechnology company that develops AAV-based gene therapies to treat retinal and neurological diseases.
Sector
Enterprise Software
Verticals
Workflow Automation, Project Management, Platform-as-a-Service
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elisigen Comparables
Compare Elisigen with similar companies based on industry and business-model similarity.
Elisigen Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jan 19, 2026 | ||||
| Series B | Jun 3, 2021 | ||||
| Series A | Apr 30, 2019 | ||||
| Seed | Oct 25, 2018 |
Elisigen Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SV Investment | Series B |
| KB Investment | Series C |
| Seven Tree Equity Partners | Series B |
| Ulmus Investment | Series B |
| Premier Partners | Series C |
| NICE F&I | Series C |
| QUAD Investment Management | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 19, 2026
$29M round with participation from NH Investment & Securities and Premier Partners.
- May 21, 2024
Grew 67% QoQ, from 6 to 10 employees.
Elisigen Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Elisigen's valuation, stock price, and market status.